Skip to content

Retrospective Analysis of Midazolam Hydrochloride Oral Solution for Preoperative Anxiety and Sedation in Pediatric Patients: Evaluation of Efficacy and Safety

Retrospective Analysis of Midazolam Hydrochloride Oral Solution for Preoperative Anxiety and Sedation in Pediatric Patients: Evaluation of Efficacy and Safety

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115877
Enrollment
Unknown
Registered
2025-12-31
Start date
2025-12-31
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

preoperative anxiety and sedation

Interventions

Midazolam Hydrochloride Oral Solution Group:None

Sponsors

Sichuan Academy of Medical Sciences · Sichuan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0.5 Years to 16 Years

Inclusion criteria

Inclusion criteria: 1.Aged between 6 months and 16 years (inclusive), either sex. 2.Scheduled for elective surgery (e.g., in general surgery, urology, orthopedics, otorhinolaryngology, or stomatology) requiring preoperative sedative medication. 3.Legal guardian and/or the patient (where applicable) provided consent to participate in the trial and voluntarily signed the informed consent form. (Legal guardians signed the guardian version; children aged 8 years or older also provided assent by signing a minor-specific informed consent form).

Exclusion criteria

Exclusion criteria: 1.Known hypersensitivity to any component of midazolam oral solution. 2.Diagnosis of acute angle-closure glaucoma or inadequately treated open-angle glaucoma. 3.Concurrent participation in another interventional clinical trial. 4.Considered by the investigator to be unsuitable for participation for any other reason.

Design outcomes

Primary

MeasureTime frame
Anxiety and Ramsay Sedation Scores in Children in the Midazolam Hydrochloride Oral Solution Group at the Following Time Points: 1 hour before drug administration (T0) Every 5–10 minutes after administration (T1, T2, T3, T4, T5);Children's Cooperation Score During Anesthesia Induction;Satisfaction of Postoperative Pediatric Caregivers and Anesthesiologists with Drug Administration;

Secondary

MeasureTime frame
Pediatric PACU Recovery Time;Vital Signs in Children After Drug Administration, Including SpO? (Pulse Oximetry), Respiratory Rate, and Heart Rate;

Countries

China

Contacts

Public ContactTang Xiaolin

Department of Anesthesiology, Sichuan Academy of Medical Sciences · Sichuan Provincial People's Hospital

Adolph-xl@outlook.com+86 134 1926 6375

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026